NCT06286917 Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency
| NCT ID | NCT06286917 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tampere University |
| Condition | Ventilation Therapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-03-05 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-03-05 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.
Eligibility Criteria
Inclusion Criteria: * ALS diagnosed by a neurology and * chronic respiratory insufficiency or significant respiratory muscle weakness caused by ALS Exclusion Criteria: * impaired cognition to give informed consent to participation * contraindication to NIV therapy * another severe disease with a prognosis of less than one year * ventilation via an artificial airway, tracheostomy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06286917 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Ventilation Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06286917 currently recruiting?
Yes, NCT06286917 is actively recruiting participants. Contact the research team at heidi.rantala@tuni.fi for enrollment information.
Where is the NCT06286917 trial being conducted?
This trial is being conducted at Tampere, Finland.
Who is sponsoring the NCT06286917 clinical trial?
NCT06286917 is sponsored by Tampere University. The trial plans to enroll 120 participants.